Resveratrol alleviates DSS-induced IBD in mice by regulating the intestinal microbiota-macrophage-arginine metabolism axis
Abstract Background Inflammatory bowel disease (IBD) is a global disease with a growing public health concern and is associated with a complex interplay of factors, including the microbiota and immune system. Resveratrol, a natural anti-inflammatory and antioxidant agent, is known to relieve IBD but...
Main Authors: | Xinwei Xu, Dickson Kofi Wiredu Ocansey, Bing Pei, Yaqin Zhang, Naijian Wang, Zengxu Wang, Fei Mao |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2023-09-01
|
Series: | European Journal of Medical Research |
Subjects: | |
Online Access: | https://doi.org/10.1186/s40001-023-01257-6 |
Similar Items
-
hucMSC-Ex Alleviates IBD-Associated Intestinal Fibrosis by Inhibiting ERK Phosphorylation in Intestinal Fibroblasts
by: Yifei Wang, et al.
Published: (2023-01-01) -
Role of glycolysis in inflammatory bowel disease and its associated colorectal cancer
by: Yuxuan Xia, et al.
Published: (2023-10-01) -
The role of mesenchymal stem cell-derived exosome in epigenetic modifications in inflammatory diseases
by: Zihan Zhao, et al.
Published: (2023-05-01) -
trans-Resveratrol Ameliorates Stress-Induced Irritable Bowel Syndrome-Like Behaviors by Regulation of Brain-Gut Axis
by: Ying Xu, et al.
Published: (2018-06-01) -
PROPERTIES OF NANO ENCAPSULATED L-ARGININE AND RESVERATROL IN WATER-SOLUBLE POLYMERS
by: Ilya Bogachev, et al.
Published: (2015-12-01)